Muraglitazar
(Redirected from Pargluva)
Muraglitazar is a peroxisome proliferator-activated receptor (PPAR) agonist that was developed for the treatment of type 2 diabetes. It was designed to activate both PPAR-alpha and PPAR-gamma receptors, which are involved in glucose metabolism and lipid metabolism, respectively. However, the drug was withdrawn from development due to concerns about its safety profile.
History[edit | edit source]
Muraglitazar was developed by Bristol-Myers Squibb in the early 2000s. It was one of several dual PPAR agonists being developed at the time, which were hoped to provide better glucose control and lipid-lowering effects than the existing thiazolidinedione class of drugs. However, in 2006, Bristol-Myers Squibb announced that it was discontinuing development of muraglitazar due to concerns about its safety profile.
Mechanism of Action[edit | edit source]
Muraglitazar acts as a dual PPAR agonist, activating both PPAR-alpha and PPAR-gamma receptors. PPAR-alpha receptors are primarily involved in lipid metabolism, and their activation can lead to reductions in triglyceride levels and increases in high-density lipoprotein (HDL) cholesterol. PPAR-gamma receptors, on the other hand, are involved in glucose metabolism, and their activation can improve insulin sensitivity and reduce blood glucose levels.
Safety Concerns[edit | edit source]
The safety concerns that led to the discontinuation of muraglitazar primarily related to an increased risk of cardiovascular disease. In a meta-analysis of clinical trial data, muraglitazar was found to be associated with a significant increase in the risk of major adverse cardiovascular events, including heart attack and stroke. This led to the decision by Bristol-Myers Squibb to discontinue development of the drug.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD